Ocugen (NASDAQ:OCGN) stock fans will want to keep an eye on the clinical-stage biopharmaceutical company as it has big news coming on Wednesday. That’s when Ocugen plans to hold a Clinical Showcase covering the company’s upcoming Phase 3 trial of OCU400. The event is set to start at 10:00 a.m. Eastern Time tomorrow and will last until noon. To go along with this, the company says it will include details from its ongoing Phase 1/2 trial of OCU400 during that Clinical Showcase. All of this is related to OCU40 ...